Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Accumulated Expenses (2017 - 2021)

Historic Accumulated Expenses for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $7.0 million.

  • Cogent Biosciences' Accumulated Expenses rose 2731.71% to $7.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $7.0 million, marking a year-over-year increase of 2731.71%. This contributed to the annual value of $4.8 million for FY2020, which is 3298.28% down from last year.
  • As of Q3 2021, Cogent Biosciences' Accumulated Expenses stood at $7.0 million, which was up 2731.71% from $6.4 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Accumulated Expenses ranged from a high of $7.1 million in Q4 2019 and a low of $357000.0 during Q1 2018
  • In the last 5 years, Cogent Biosciences' Accumulated Expenses had a median value of $5.6 million in 2020 and averaged $4.7 million.
  • In the last 5 years, Cogent Biosciences' Accumulated Expenses soared by 159943.98% in 2019 and then plummeted by 5508.74% in 2021.
  • Cogent Biosciences' Accumulated Expenses (Quarter) stood at $3.0 million in 2017, then surged by 85.47% to $5.5 million in 2018, then soared by 30.2% to $7.1 million in 2019, then crashed by 32.98% to $4.8 million in 2020, then skyrocketed by 47.46% to $7.0 million in 2021.
  • Its Accumulated Expenses was $7.0 million in Q3 2021, compared to $6.4 million in Q2 2021 and $2.8 million in Q1 2021.